Skip to main content
. 2015 Jul-Aug;9(7-8):263–267. doi: 10.5489/cuaj.2377

Table 4.

Univariate and multivariable Cox analysis for overall survival

OS Univariate Cox regression Multivariable Cox regression

HR (95% CI) p value HR (95% CI) p value
Heng prognostic group
  Good vs. poor 0.15 (0.07–0.31) <0.001 0.17 (0.08–0.37) <0.001
  Intermediate vs. poor 0.28 (0.16–0.53) <0.001 0.27 (0.15–0.50) <0.001
BM (Y/N) 1.84 (1.25–2.72) 0.002 1.81 (1.21–2.70) 0.003
Sites of metastases ≥ 2 (Y/N) 1.72 (0.92–3.23) 0.088
Therapy (SO vs. EV) 2.43 (1.65–3.63) <0.001 2.21 (1.47–3.31) <0.001

OS: overall survival; BM: bone metastases, CI: confidence interval; HR: hazard ratio; Y: yes; N: no; EV: everolimus; SO: sorafenib.